followers 13 popularity
following 1

following  view all

markhub is not in any groups

Global Duchenne Muscular Dystrophy Drugs Market Research Industry Analysis, Outlook during 2019-2025

Mar 14th 2019 at 5:39 AM

A newly compiled business intelligent report, titled “Global Duchenne Muscular Dystrophy Drugs Market” Research Report 2019 has been publicized to the vast archive of Market Research Hub (MRH) online repository. The study revolves around the analysis of Duchenne Muscular Dystrophy Drugs Market, covering key industry developments and market opportunity map during the mentioned forecast period. This report further conveys quantitative & qualitative analysis on the concerned market, providing a 360 view on current and future market prospects. As the report proceeds, information regarding the prominent trends as well as opportunities in the key geographical segments have also been explained, thus enabling companies to be able to make region-specific strategies for gaining competitive lead.

Request for sample report @

Duchenne muscular dystrophy is an X-linked disease, which generally affects the male population. It is characterized by progressive muscle degeneration and weakness. The disease is caused due to mutations in the dystrophin gene, which result in the lack of production of dystrophin (a protein essential for maintaining healthy muscle function) in individuals. The lack of dystrophin weakens muscle function, causes loss of ambulation, harms the respiratory and cardiac function, and ultimately leads to death.
The main symptoms of this condition appears in childhood and includes delay of motor functions; progressive muscle weakness; muscle contractures in legs; and muscle weakness in arms, neck, and more severely in the lower half of the body. The bones also develop peculiarly, causing skeletal deformities in the patient. Occurrences of pseudo-hypertrophy, cardiomyopathy, and breathing complications are some of the other symptoms of this condition.

The global Duchenne Muscular Dystrophy Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Duchenne Muscular Dystrophy Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Duchenne Muscular Dystrophy Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, and revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Akashi Therapeutics Inc
Antisense Therapeutics Ltd
Beech Tree Labs Inc
Biogen Inc
Bioleaders Corp
BioMarin Pharmaceutical Inc
Biophytis SAS
Capricor Therapeutics Inc
Catabasis Pharmaceuticals Inc
CRISPR Therapeutics
Cumberland Pharmaceuticals Inc
Daiichi Sankyo Co Ltd
Debiopharm International SA
Editas Medicine Inc
Eloxx Pharmaceuticals Inc
F. Hoffmann-La Roche Ltd
FibroGen Inc
Fulcrum Therapeutics Inc
Galapagos NV
Genethon SA
GTx Inc
Santhera Pharmaceuticals Holding AG
Sarepta Therapeutics Inc
SOM Biotech SL
Strykagen Corp
Summit Therapeutics Plc
Taiho Pharmaceutical Co Ltd
Teijin Pharma Ltd
WAVE Life Sciences Ltd

Segment by Regions
North America

Segment by Type
Development & Drug Target
Mechanism of Action (MoA)
Route of Administration (RoA)
Molecule Type

Segment by Application
Hospitals and Clinics
Medical Laboratories

Top of Form

Browse Full Report with TOC@

Table of Contents

Executive Summary
1 Duchenne Muscular Dystrophy Drugs Market Overview
1.1 Product Overview and Scope of Duchenne Muscular Dystrophy Drugs
1.2 Duchenne Muscular Dystrophy Drugs Segment by Type
1.2.1 Global Duchenne Muscular Dystrophy Drugs Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Development & Drug Target
1.2.3 Mechanism of Action (MoA)
1.2.4 Route of Administration (RoA)
1.2.5 Molecule Type
1.3 Duchenne Muscular Dystrophy Drugs Segment by Application
1.3.1 Duchenne Muscular Dystrophy Drugs Consumption Comparison by Application (2014-2025)
1.3.2 Hospitals and Clinics
1.3.3 Medical Laboratories
1.3.4 Others
1.4 Global Duchenne Muscular Dystrophy Drugs Market by Region
1.4.1 Global Duchenne Muscular Dystrophy Drugs Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Duchenne Muscular Dystrophy Drugs Market Size
1.5.1 Global Duchenne Muscular Dystrophy Drugs Revenue (2014-2025)
1.5.2 Global Duchenne Muscular Dystrophy Drugs Production (2014-2025)


Enquire about This Report @

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports of different sector like Pharmaceuticals market research and analysis. MRH’s expansive collection of industry reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)



Read Industry News at:



Please to comment

sign in

Remember Me

New to IM faceplate? join free!

Lost Password? click here